103 related articles for article (PubMed ID: 38746764)
1. Drug Monographs: Trabectedin and Trifluridine-Tipiracil.
Solimando DA; Waddell JA
Hosp Pharm; 2016 Feb; 51(2):120-128. PubMed ID: 38746764
[TBL] [Abstract][Full Text] [Related]
2. Drug Monographs: Avelumab and Ribociclib.
Waddell JA; Solimando DA
Hosp Pharm; 2017 Jul; 52(7):459-463. PubMed ID: 29276273
[TBL] [Abstract][Full Text] [Related]
3. Drug Monographs: Ixazomib and Necitumumab.
Lawson FE; Waddell JA; Solimando DA
Hosp Pharm; 2016 May; 51(5):362-6. PubMed ID: 27303088
[TBL] [Abstract][Full Text] [Related]
4. Drug Monographs: Daratumumab and Osimertinib.
Solimando DA; Waddell JA
Hosp Pharm; 2016 Apr; 51(4):288-92. PubMed ID: 27303075
[TBL] [Abstract][Full Text] [Related]
5. Drug monographs: belinostat and idelalisib.
Piper WL; Waddell JA; Solimando DA
Hosp Pharm; 2014 Dec; 49(11):1009-13. PubMed ID: 25673888
[TBL] [Abstract][Full Text] [Related]
6. Drug monographs: ibrutinib and ramucirumab.
Solimando DA; Waddell JA
Hosp Pharm; 2014 Sep; 49(8):702-9. PubMed ID: 25477594
[TBL] [Abstract][Full Text] [Related]
7. Drug monographs: afatinib and obinutuzumab.
Mancheril BG; Aubrey Waddell J; Solimando DA
Hosp Pharm; 2014 Mar; 49(3):237-41. PubMed ID: 24715741
[TBL] [Abstract][Full Text] [Related]
8. Drug monographs: pomalidomide and ponatinib.
Butler TW; Waddell JA; Solimando DA
Hosp Pharm; 2013 Sep; 48(8):636-41. PubMed ID: 24421531
[TBL] [Abstract][Full Text] [Related]
9. Drug monographs: cabozantanib and omacetaxine.
Solimando DA; Ho KV; Waddell JA
Hosp Pharm; 2013 May; 48(5):373-7. PubMed ID: 24421492
[TBL] [Abstract][Full Text] [Related]
10. Drug monographs: bosutinib and regorafenib.
Solimando DA; Waddell JA
Hosp Pharm; 2013 Mar; 48(3):190-4. PubMed ID: 24421459
[TBL] [Abstract][Full Text] [Related]
11. Drug monographs: dabrafenib and trametinib.
Waddell JA; Solimando DA
Hosp Pharm; 2013 Nov; 48(10):818-21. PubMed ID: 24421433
[TBL] [Abstract][Full Text] [Related]
12. Drug Monographs: Ziv-aflibercept and Vincristine Sulfate Liposome.
Lee JN; Solimando DA; Waddell JA
Hosp Pharm; 2013 Jan; 48(1):14-22. PubMed ID: 24421416
[TBL] [Abstract][Full Text] [Related]
13. Cobimetinib and Irinotecan Liposome.
Pickren EB; Waddell JA; Solimando DA
Hosp Pharm; 2016 Mar; 51(3):208-211. PubMed ID: 38745581
[TBL] [Abstract][Full Text] [Related]
14. Pertuzumab, Trastuzumab, and Docetaxel for HER2-Positive Breast Cancer.
Cheng RM; Waddell JA; Solimando DA
Hosp Pharm; 2016 Jan; 51(1):35-38. PubMed ID: 38745714
[TBL] [Abstract][Full Text] [Related]
15. Drug Monographs: Olaratumab and Rucaparib.
Solimando DA; Waddell JA
Hosp Pharm; 2017 Apr; 52(4):258-263. PubMed ID: 28515503
[TBL] [Abstract][Full Text] [Related]
16. Drug Monographs: Atezolizumab and Everolimus.
Green MA; Waddell JA; Solimando DA
Hosp Pharm; 2016 Nov; 51(10):810-814. PubMed ID: 27928185
[TBL] [Abstract][Full Text] [Related]
17. Gefitinib and Sonidegib.
Medler CJ; Waddell JA; Solimando DA
Hosp Pharm; 2015 Nov; 50(10):868-872. PubMed ID: 27729673
[TBL] [Abstract][Full Text] [Related]
18. Dinutuximab and Panobinostat.
Chasick A; Solimando DA; Waddell JA
Hosp Pharm; 2015 Oct; 50(9):767-72. PubMed ID: 26912916
[TBL] [Abstract][Full Text] [Related]
19. Lenvatinib and Palbociclib.
Solimando DA; Waddell JA
Hosp Pharm; 2015 Jul; 50(7):578-82. PubMed ID: 26448668
[TBL] [Abstract][Full Text] [Related]
20. Blinatumomab and Pembrolizumab.
Tabor EE; Waddell JA; Solimando DA
Hosp Pharm; 2015 Apr; 50(4):269-73. PubMed ID: 26448656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
